StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by valentinemassonon Aug 20, 2020 4:52pm

150 Views

Post# 31435753

RE:RE:took out all the .055

LithLover wrote: Don't mention warrants on this board LOL. Apparently it makes some very upset despite the fact that warrants are a higher risk v reward and actuially show more of a commitment to waiting for a much higher share price. 3 year warrants given all the good things coming. I can't believe they are still under 0.07
gimmycash wrote: warrants.who is going to take out the .06s.

Good point, can warrants can be called in at anytime, ie) accelerate the maturity date? If there is a reverse split, assuming they are also affected to the same ratio, are these items correct? Thanks,

Bullboard Posts

Anaergia expands relationship with PepsiCo